Strides Pharmas Singapore Arm Gets Usfda Nod For Generic Version Of Oseltamivir Phosphate
The Product Is Bioequivalent And Therapeutically Equivalent To The Reference Listed Drug (Rld), Tamiflu For Oral Suspension, 6 Mg/Ml, Of Hoffmann-La Roche, Inc, It Added Strides Pharma Science Ltd On Monday Said Its Singapore-Based Arm Has Received Approval From The Us Health Regulator For Its Generic Version Of Oseltamivir Phosphate For Oral Suspension, Used For Treating Illness Due To Influenza. The Approval Granted By The Us Food & Drug Administration (Usfda) To Strides Pharma Global Pte. Ltd, Singapore, Is For Oseltamivir Phosphate For Oral Suspension Of Strength 6 Mg/Ml, The Company Said In A Statement Https://Health.Economictimes.Indiatimes.Com/News/Pharma/Strides-Pharmas-Singapore-Arm-Gets-Usfda-Nod-For-Generic-Version-Of-Oseltamivir-Phosphat
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
